Home » Teva Receives Tentative Approval for Generic Topiramate
Teva Receives Tentative Approval for Generic Topiramate
Teva Pharmaceutical has received tentative approval from the FDA to market topiramate capsules in 15- and 25-mg strengths.
Topiramate is the generic equivalent of Ortho-McNeil Pharmaceutical's Topamax, and is used to treat migraines and cluster headaches, epilepsy, and weight loss.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
07May
-
14May
-
30May